Among the last, pathogenic variants in the transcription factor gene SOX2 have been reported as causative in 10–20% of the individuals with anophthalmia or severe microphthalmia, and in up to 40% of those affected bilaterally (7,8). This evidence concerns the gene SOX2 and Anophthalmia.